Listar Biologie des maladies cardiovasculaires (BMC) - UMR 1034 por autor "RANTA, Dana"
Mostrando ítems 1-4 de 4
-
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
LUQUE PAZ, Damien; RIOU, Jeremie; VERGER, Emmanuelle ...(Blood Advances. vol. 5, n° 5, pp. 1442-1451, 2021-03-09)Article de revue -
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
SUREAU, Léa; BUORS, Caroline; IANOTTO, Jean-Christophe ...(Blood Cancer Journal. vol. 12, n° 4, pp. 56, 2022-04-08)Article de revueLibre acceso -
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
AUBIN, Laura; VILAS BOAS, Rúben; DALTRO DE OLIVEIRA, Rafael ...(American Journal of Hematology, 2024-02-25)Article de revueLibre acceso